lynozyfichcp.com

Learn about LYNOZYFIC™, approved in 5L+ R/R multiple myeloma. See full Prescribing Information, including Boxed WARNING, and Important Safety Information.
Social
N/A
App
Category
Monetization
Unknown
Domain Information
Site Overview
Site Engagments
86.96%
Bounce Rate
Pages Per Visit
1
Total Visits
5.4K
Time on Site
00:06:48
Traffic Sources
Social
8.34%
Paid
1.24%
Mail
0.10%
Referrals
5.08%
Search
76.44%
Direct
8.78%
Traffic Top 5 Country
100.00%
Google Ads Overview
Data provided by PoleCreative
Google SEO Overview
Posts
TitleAuthorViewCommentsLast Update